TY  - BOOK
AU  - Aranda,Jacob V.
AU  - Van den Anker,John N.
TI  - Yaffe and Aranda's neonatal and pediatric pharmacology: therapeutic principles in practice 
SN  - 9781975112493
AV  - RJ560 
U1  - 615.1083 23
PY  - 2021///]
CY  - Philadelphia
PB  - Wolters Kluwer
KW  - Pediatric pharmacology
KW  - Children
KW  - Diseases
KW  - Chemotherapy
KW  - Infants
KW  - Drugs
KW  - Dosage
KW  - Drug Therapy
KW  - Child
KW  - Infant
KW  - Pharmaceutical Preparations
KW  - administration & dosage
KW  - Pharmacological Phenomena
KW  - Pharmacologie pédiatrique
KW  - Enfants
KW  - Maladies
KW  - Chimiothérapie
KW  - Nourrissons
KW  - Posologie
KW  - children (people by age group)
KW  - aat
KW  - infants
KW  - fast
N1  - Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed; Includes bibliographical references and index; Section I; General principles; Clinical trials involving children: history, rationale, regulatory framework, and technical considerations; Clinical pharmacokinetics in infants and children; Developmental pharmacodynamics, receptor function, and drug actions in newborns and children; Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children; Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children; Ethics of drug research in newborns and children; Precision medicie and therapeutic drug monitoring; Drug formulations for children --; Section II; Pharmacology in special settings and population: the newborn; Role of placenta in drug metabolism and drug transfer; Maternal medications during pregnancy and lactation; Principles of neonatal pharmacology; Renal function and excretion of drugs in the newborn; Neuroprotective drugs and perinatal brain injury; Pharmacologic agents for neonatal hyperbilirubinemia; Pharmacologic treatment of neonatal apnea --; Section III; Pharmacology in special settings and population; Therapeutic applications in pediatric intensive care; Drug therapy in the pediatric emergency department; Topical medications; Ophthalmologic drugs in infants and children --; Section IV; Antimicrobial pharmacology; Penicillins, cephalosporins, and other [beta]-lactams; Glycopeptides, lipoglycopeptides, and lipopeptides; Aminoglycosides; Macrolides, clindamycin, and oxazolidinones; Fluoroquinolones; Sulfonamides, dihydrofolate reductase inhibitors, and dapsone; Tetracyclines, chloramphenicol, and metronidazole; Antimalarials; Anthelminthics drugs in children; Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria); Antifungal agents; Antivirals in newborns and children; Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns --; Section V; Neuropharmacology; Anticonvulsants; Antidepressants and mood stabilizers; Stimulants, ADHD treatments, and antipsychotics; Analgesics and sedatives; Pharmacologic management of neonatal abstinence syndrome; Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents --; Section VI; Immunopharmacology, allergy, and inflammation; Nonsteroida anti-inflammatory drugs; Antihistamine drugs; Antiasthmatics; Immunosuppressive and immunomodulatory drugs --; Section VII; Pharmacology of biologic drugs; Microbial therapeutics: beyond probiotics; Monoclonal antibiotics; Stem cells; Drugs, lung development, and pulmonary surfactant; Childhood vaccines --; Section VIII; Cardiorenal drugs; Neonatal cardiovascular pharmacology; Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management; Antihypertensive drugs; Diuretics --; Section IX; Gastrointestinal pharmacology; Gastrointestinal drugs; Drugs in inflammatory bowel disease --; Section X; Endocrine and hematologic pharmacology; Glucocorticoids; Insulin and diabetes; Growth hormone; Thyroid hormones; Hematologic agents; Clinical pharmacology of antineoplastic drugs --; Section XI; Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions; Nutrient supplements; Herbal drugs in children; Pediatric poisonings and antidotes; Adverse drug reactions in newborns and children; Medication errors in children; Drug interactions in newborns and children --; Appendix A1; Neonatal drug formulary --; Appendix A2; Pediatric drug formulary
N2  - "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3241830
ER  -